TABLE 1

Patient Demographics and Clinical Characteristics

Patients, n81
Age (y), mean (range)65 (47–77)
PSA (ng/mL), mean (range)10.2 (2.3–27)
Bone scan before inclusion
 Planar whole body49
 Planar whole body + SPECT/CT32
Gleason
 < 7, n5
 7 (3 + 4), n46
 7 (4 + 3), n18
 > 7, n12
T-stage
 T1, n41
 T2, n39
 T3, n1
EAU risk score
 Intermediate risk, n60
 High risk, n21
PSA response 6 mo after RP
 Biochemical response*, n75
 Biochemical failure†, n6

  • ↵* PSA < 0.2 ng/mL at 6 wk and at 6 mo after radical prostatectomy.

  • ↵† PSA ≥ 0.2 ng/mL at 6 wk or at 6 mo after radical prostatectomy.

  • EAU = European Association of Urology; PSA = prostate-specific antigen; RP = radical prostatectomy.